|
MRPL35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.46139999999984E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.136100E-03 |
| Normal-vs-Stage2 |
8.986000E-01 |
| Normal-vs-Stage3 |
2.23550000000294E-06 |
| Normal-vs-Stage4 |
2.7458999962704E-08 |
| Stage1-vs-Stage2 |
6.408500E-02 |
| Stage1-vs-Stage3 |
1.686160E-02 |
| Stage1-vs-Stage4 |
2.218300E-04 |
| Stage2-vs-Stage3 |
1.699630E-03 |
| Stage2-vs-Stage4 |
1.633780E-04 |
| Stage3-vs-Stage4 |
1.831240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76083999999799E-05 |
| Normal-vs-AfricanAmerican |
6.181300E-03 |
| Normal-vs-Asian |
4.371500E-02 |
| Caucasian-vs-AfricanAmerican |
3.585200E-01 |
| Caucasian-vs-Asian |
4.723400E-01 |
| AfricanAmerican-vs-Asian |
2.248400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.612000E-04 |
| Normal-vs-Female |
1.208650E-04 |
| Male-vs-Female |
7.359200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.759700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.49789999999805E-05 |
| Normal-vs-Age(61-80Yrs) |
5.879300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.629520E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.262800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.928800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.148000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.575400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.949800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.098400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.165700E-02 |
| Classical-VS-Follicular |
1.231750E-02 |
| Classical-VS-Other |
6.267600E-01 |
| Classical-VS-Normal |
1.382260E-04 |
| Tall-VS-Follicular |
1.416880E-03 |
| Tall-VS-Other |
7.318000E-01 |
| Tall-VS-Normal |
2.159100E-04 |
| Follicular-VS-Other |
1.721050E-01 |
| Follicular-VS-Normal |
4.298200E-01 |
| Other-VS-Normal |
2.347400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.461400E-03 |
| Normal-vs-N1 |
1.78740999999816E-05 |
| N0-vs-N1 |
9.659800E-03 |
|
|
